Hoth Therapeutics Inc. (HOTH)
NASDAQ: HOTH
· Real-Time Price · USD
1.81
-0.14 (-7.18%)
At close: Sep 25, 2025, 3:59 PM
1.85
2.16%
After-hours: Sep 25, 2025, 05:09 PM EDT
-7.18% (1D)
| Bid | 1.79 |
| Market Cap | 24M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -10.19M |
| EPS (ttm) | -1.04 |
| PE Ratio (ttm) | -1.74 |
| Forward PE | -3.51 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.87 |
| Volume | 1,470,988 |
| Avg. Volume (20D) | 970,574 |
| Open | 1.90 |
| Previous Close | 1.95 |
| Day's Range | 1.71 - 1.90 |
| 52-Week Range | 0.65 - 3.80 |
| Beta | 0.68 |
| Ex-Dividend Date | n/a |
About HOTH
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HOTH
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for HOTH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+10.34%
Hoth Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
8 months ago
+178.18%
Hoth Therapeutics shares are trading higher after the company announced safety results from its Phase 2a trial, showing that 100% of patients in Cohort 1 achieved the primary efficacy endpoint.
